| Robert Ezewuiro, | |
|
1190 Highway 9 Byp W, Lancaster, SC 29720-1709 | |
| (803) 285-1411 | |
| Not Available |
| Full Name | Robert Ezewuiro |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 5 Years |
| Location | 1190 Highway 9 Byp W, Lancaster, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134571334 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Piedmont Medical Center | Rock hill, SC | Hospital |
| Musc Health Lancaster Medical Center | Lancaster, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Instride Foot And Ankle Specialists, Pllc | 7012168271 | 55 |
News Archive
Agendia, a world leader in molecular cancer diagnostics, announced today that Palmetto GBA, California's Part B Medicare administrator, has established coding guidelines for the company's MammaPrint test.
Nektar Therapeutics today announced positive results from a Phase 2 clinical study evaluating single-agent NKTR-102 in patients with metastatic breast cancer during the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). NKTR-102, a novel investigational topoisomerase I inhibitor-polymer conjugate, is Nektar's lead oncology candidate and is being evaluated in multiple cancer indications.
Researchers at the Salk Institute for Biological Studies have identified an important circuit in the spinal cord that controls the speed with which our leg muscles contract and relax.
A simple blood test can quickly identify what type of congestive heart failure (CHF) a patient has, improving diagnostic accuracy; eliminating the need for extensive diagnostic tests, such as heart muscle biopsy or exploratory surgery; and enabling the patient to be treated sooner, according to a study published in the June 7 Journal of the American College of Cardiology.
› Verified 7 days ago
| Provider Name | Instride Foot & Ankle Specialists, Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1457601601 PECOS PAC ID: 7012168271 Enrollment ID: O20151218001546 |
News Archive
Agendia, a world leader in molecular cancer diagnostics, announced today that Palmetto GBA, California's Part B Medicare administrator, has established coding guidelines for the company's MammaPrint test.
Nektar Therapeutics today announced positive results from a Phase 2 clinical study evaluating single-agent NKTR-102 in patients with metastatic breast cancer during the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). NKTR-102, a novel investigational topoisomerase I inhibitor-polymer conjugate, is Nektar's lead oncology candidate and is being evaluated in multiple cancer indications.
Researchers at the Salk Institute for Biological Studies have identified an important circuit in the spinal cord that controls the speed with which our leg muscles contract and relax.
A simple blood test can quickly identify what type of congestive heart failure (CHF) a patient has, improving diagnostic accuracy; eliminating the need for extensive diagnostic tests, such as heart muscle biopsy or exploratory surgery; and enabling the patient to be treated sooner, according to a study published in the June 7 Journal of the American College of Cardiology.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Ezewuiro, 10800 Knights Rd, Philadelphia, PA 19114-4200 Ph: (215) 612-4000 | Robert Ezewuiro, 1190 Highway 9 Byp W, Lancaster, SC 29720-1709 Ph: (803) 285-1411 |
News Archive
Agendia, a world leader in molecular cancer diagnostics, announced today that Palmetto GBA, California's Part B Medicare administrator, has established coding guidelines for the company's MammaPrint test.
Nektar Therapeutics today announced positive results from a Phase 2 clinical study evaluating single-agent NKTR-102 in patients with metastatic breast cancer during the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). NKTR-102, a novel investigational topoisomerase I inhibitor-polymer conjugate, is Nektar's lead oncology candidate and is being evaluated in multiple cancer indications.
Researchers at the Salk Institute for Biological Studies have identified an important circuit in the spinal cord that controls the speed with which our leg muscles contract and relax.
A simple blood test can quickly identify what type of congestive heart failure (CHF) a patient has, improving diagnostic accuracy; eliminating the need for extensive diagnostic tests, such as heart muscle biopsy or exploratory surgery; and enabling the patient to be treated sooner, according to a study published in the June 7 Journal of the American College of Cardiology.
› Verified 7 days ago
Dr. William Harris Iv, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1190 Highway 9 Byp W, Lancaster, SC 29720 Phone: 803-804-5964 Fax: 803-283-9920 | |
South Carolina Podiatric Physicians And Surgeons Group, Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1190 Highway 9 Byp W, Lancaster, SC 29720 Phone: 803-285-1411 Fax: 803-283-9920 | |
Instride Foot And Ankle Specialists, Pllc Podiatrist Medicare: Medicare Enrolled Practice Location: 1190 Highway 9 Byp W, Lancaster, SC 29720 Phone: 803-285-1411 | |
Mrs. Julie Welsh Percival, D.P.M. Podiatrist Medicare: Medicare Enrolled Practice Location: 1190 Highway 9 Byp W, Lancaster, SC 29720 Phone: 803-285-1411 Fax: 803-283-9920 | |
Carolina Podiatry Group, Inc. Podiatrist Medicare: Medicare Enrolled Practice Location: 1190 Highway 9 Byp W, Lancaster, SC 29720 Phone: 803-285-1411 Fax: 803-283-9920 | |
Katlin Ann O'hara, D.P.M Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1190 Highway 9 Byp W, Lancaster, SC 29720 Phone: 803-285-1411 |